Low-Dose Naltrexone for Lyme: What We Know (and Don’t)
Low-dose naltrexone (LDN) has gained growing attention as a potential supportive therapy for people with chronic Lyme disease and persistent symptoms that may not fully resolve with antibiotics. Originally developed as a treatment for opioid and alcohol dependence, naltrexone in much smaller doses appears to have immune-modulating and anti-inflammatory effects. For patients struggling with lingering […]
Low-Dose Naltrexone for Lyme: What We Know (and Don’t) Read More »